These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11193809)

  • 21. Estrogen and cerebral blood flow: a mechanism to explain the impact of estrogen on the incidence and treatment of Alzheimer's disease.
    Greene RA
    Int J Fertil Womens Med; 2000; 45(4):253-7. PubMed ID: 10997480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen replacement therapy for the potential treatment or prevention of Alzheimer's disease.
    Miller MM; Monjan AA; Buckholtz NS
    Ann N Y Acad Sci; 2001 Dec; 949():223-34. PubMed ID: 11795357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen and Alzheimer's disease: the story so far.
    Cholerton B; Gleason CE; Baker LD; Asthana S
    Drugs Aging; 2002; 19(6):405-27. PubMed ID: 12149049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oestrogens and dementia.
    Henderson VW
    Novartis Found Symp; 2000; 230():254-65; discussion 265-73. PubMed ID: 10965513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hippocampal estrogen beta-receptor immunoreactivity is increased in Alzheimer's disease.
    Savaskan E; Olivieri G; Meier F; Ravid R; Müller-Spahn F
    Brain Res; 2001 Jul; 908(2):113-9. PubMed ID: 11454321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationships between mood and estradiol (E2) levels in Alzheimer's disease (AD) patients.
    Carlson LE; Sherwin BB; Chertkow HM
    J Gerontol B Psychol Sci Soc Sci; 2000 Jan; 55(1):P47-53. PubMed ID: 10728123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Estrogens and Alzheimer's disease: rationale, promises, and facts].
    Martínez Lage JM; Oliveros-Cid A; Martínez-Lage P
    Med Clin (Barc); 2000 May; 114(19):747-55. PubMed ID: 10919131
    [No Abstract]   [Full Text] [Related]  

  • 28. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen associated gene polymorphisms and their interactions in the progress of Alzheimer's disease.
    Xing Y; Jia JP; Ji XJ; Tian T
    Prog Neurobiol; 2013 Dec; 111():53-74. PubMed ID: 24096044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Estrogens and Alzheimer disease].
    Stähelin HB
    Schweiz Med Wochenschr; 1999 Dec; 129(49):1920-5. PubMed ID: 10635084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular and molecular basis of estrogen's neuroprotection. Potential relevance for Alzheimer's disease.
    Inestrosa NC; Marzolo MP; Bonnefont AB
    Mol Neurobiol; 1998; 17(1-3):73-86. PubMed ID: 9887447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogens and hormone replacement therapy: is there a role in the preservation of cognitive function?
    Bieber EJ; Cohen DP
    Int J Fertil Womens Med; 2001; 46(4):206-9. PubMed ID: 11563830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's disease.
    Casadesus G; Garrett MR; Webber KM; Hartzler AW; Atwood CS; Perry G; Bowen RL; Smith MA
    Drugs R D; 2006; 7(3):187-93. PubMed ID: 16752944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroprotective effects of estradiol-17beta: implications for psychiatric disorders.
    Kölsch H; Rao ML
    Arch Womens Ment Health; 2002 Nov; 5(3):105-10. PubMed ID: 12510213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging.
    Kawas C; Resnick S; Morrison A; Brookmeyer R; Corrada M; Zonderman A; Bacal C; Lingle DD; Metter E
    Neurology; 1997 Jun; 48(6):1517-21. PubMed ID: 9191758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aromatase enzyme and Alzheimer's disease.
    Hiltunen M; Iivonen S; Soininen H
    Minerva Endocrinol; 2006 Mar; 31(1):61-73. PubMed ID: 16498364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oestrogens and Alzheimer's disease.
    Birkhäuser MH; Strnad J; Kämpf C; Bahro M
    Int J Geriatr Psychiatry; 2000 Jul; 15(7):600-9. PubMed ID: 10918340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of estrogens for the prevention and treatment of Alzheimer's disease.
    Monk D; Brodaty H
    Dement Geriatr Cogn Disord; 2000; 11(1):1-10. PubMed ID: 10629355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The epidemiology of estrogen replacement therapy and Alzheimer's disease.
    Henderson VW
    Neurology; 1997 May; 48(5 Suppl 7):S27-35. PubMed ID: 9153164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of estrogen replacement therapy in Alzheimer's disease.
    Panidis DK; Matalliotakis IM; Rousso DH; Kourtis AI; Koumantakis EE
    Eur J Obstet Gynecol Reprod Biol; 2001 Mar; 95(1):86-91. PubMed ID: 11267726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.